Fogarasi, A., & Witt, O. (2016). EFFECTS: An expanded access program of everolimus for patients with subependymal giant cell astrocytoma associated with tuberous sclerosis complex. BioMed Central; Springer. https://doi.org/10.1186/s12883-016-0658-4
Chicago-Zitierstil (17. Ausg.)Fogarasi, Andras, und Olaf Witt. EFFECTS: An Expanded Access Program of Everolimus for Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex. London; Berlin; Heidelberg: BioMed Central; Springer, 2016. https://doi.org/10.1186/s12883-016-0658-4.
MLA-Zitierstil (9. Ausg.)Fogarasi, Andras, und Olaf Witt. EFFECTS: An Expanded Access Program of Everolimus for Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex. BioMed Central; Springer, 2016. https://doi.org/10.1186/s12883-016-0658-4.